JW Pharmaceutical Reveals Observational Study Results on Hair Care Cosmetic: "Perceived Improvement and Continued Use Confirmed"

Exclusive Sales of "Ducray Neo Peptide Expert"
Large-Scale Observational Study Conducted with 1,676 Participants Across 13 Countries

A functional hair care cosmetic exclusively sold by JW Pharmaceutical has been shown to improve hair condition, according to a global observational study.

Product image of 'Ducray Neoptide Expert', a hair care cosmetic exclusively sold by JW Pharmaceutical. JW Pharmaceutical

On April 15, JW Pharmaceutical announced that the global human application test (observational study) of "Ducray Neo Peptide Expert" confirmed both improvements in users' hair condition and their intention to continue using the product.

This study was conducted on a total of 1,676 individuals across 13 countries, including Korea. Participants ranged in age from 18 to 93 and represented various skin types, allowing for observation of changes in hair condition after product use. In Korea, a separate observation was conducted with 110 Korean participants.

The results showed perceived improvements in external indicators such as hair volume, shine, and density after using the product. Similarly positive user experiences were reported even when the product was used in conjunction with existing hair care products or professional care programs. The intention to continue use was reported at 97.3% among experts and 93.6% among participants.

Ducray Neo Peptide Expert is a product developed by Pierre Fabre in France and is exclusively supplied in Korea by JW Pharmaceutical.

JW Pharmaceutical is expanding its business within the hair care product category alongside hair loss treatments such as the finasteride-based "Monade" and "Monasta," and the dutasteride-based "Dutamoa."

This content was produced with the assistance of AI translation services.